Avi Nandi

Head of Process Development

Avi Nandi is the Head of Process Development at The Center for Breakthrough Medicines. He has 15+ years of industry experience in Gene Therapy, Viral Vectors, and Vaccines with a MS in Biology and MBA (Oct ‘21) and has contributed to the regulatory approval of ZOLGENSMA in US and 10+ Rest of World markets. Avi supported a pipeline of 15+ gene therapy products in development from preclinical to Phase III development and led development and implementation of 4 gene therapy manufacturing processes across 4 GMP and 3 laboratory sites. He also has 10+ years experience in vaccine and viral vector development including, AAV, adenovirus, herpesvirus, alphavirus, lentivirus, and RNA, past experiences include:

  • AveXis / Novartis Gene Therapies – Global Head of Technical Development
  • Seqirus / CSL – Head of Virology and Cell Culture, Process and Product Development Lead
  • Novartis Vaccines and Diagnostics – Technical Development Scientist, R&D Microbial and Molecular Scientist
  • Harvard Medical School – Viral Pathogenesis Scientist